Project Abstract 136 people die each day from opioid overdose in the US. Naloxone has significantly decreased opioid mortality as a first line life-saving measure, and often it is being administered by untrained medical personnel under situations of extreme stress—which studies show leads to accidents, missed doses and tragic consequences. Pirouette has designed a novel, low-cost, and intuitive auto-injector called REZQGO that anyone could use to deliver lifesaving Naloxone safely and quickly during an opioid overdose; this Phase I project supplement will assist Pirouette in market research, regulatory planning, pricing / reimbursement strategy, usability, and the commercialization / GMP implementation of the REZQGO product lineup. Pirouete Medical Inc. Confiden�al